Study found that the antiviral molnupiravir affects the evolution of SARS-CoV-2 in immunocompromised patients, suggesting its use modifies viral mutation patterns and may impact viral evolution.
The central dogma proposed that genetic information predominantly transfers from DNA to RNA during gene expression to make a functional product protein.